SCHEMBL18359573

SCHEMBL18359573

COc1cc2c(cc1-c1c(C)noc1C)cc(C(=O)N1CCC1)c(=O)n2CCc1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ BRD4 O60885 2/20 0.40
▸ BRD2 P25440 1/20 0.40
▸ BRD3 Q15059 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ CREBBP Q92793 4/20 0.39
▸ MET P08581 1/20 0.39
▸ AXL P30530 1/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ LPAR5 Q9H1C0 1/20 0.36
▸ EP300 Q09472 1/20 0.36
▸ HDAC3 O15379 2/20 0.35
▸ HDAC4 P56524 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ HDAC7 Q8WUI4 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ HDAC10 Q969S8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18359598 0.87 CYP3A4 (0.41) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359571 0.87 CYP3A4 (0.43) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL20547087 0.85 CYP3A4 (0.42) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359666 0.84 CYP3A4 (0.48) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359594 0.84 OPRM1 (0.38) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359639 0.82 CYP3A4 (0.44) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359596 0.80 CYP3A4 (0.41) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL20547070 0.80 CYP3A4 (0.41) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL18359597 0.79 CYP3A4 (0.40) CYP3A4CYP2C9BRD4BRD2BRD3
SCHEMBL16905797 0.77 BRD4 (0.42) CYP3A4CYP2C9BRD4BRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017001733-A1 BICYCLIC HETEROCYCLE DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2017-01-05 — — WO disclosed
Send feedback